Top compounds associated with response to ADAD2


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel UHNBreast pan-cancer AAC -0.67 0.02
mRNA Crizotinib gCSI pan-cancer AAC -0.17 0.004
mRNA QS11 CTRPv2 pan-cancer AAC -0.13 0.06
mRNA lapatinib UHNBreast pan-cancer AAC -0.13 0.7
mRNA Gemcitabine gCSI pan-cancer AAC -0.12 0.03
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC -0.1 0.1
mRNA myriocin CTRPv2 pan-cancer AAC -0.1 0.3
mRNA lapatinib GDSC1000 pan-cancer AAC -0.099 0.04
mRNA Crizotinib CCLE pan-cancer AAC -0.092 0.05
mRNA Nilotinib CCLE pan-cancer AAC -0.091 0.07
Download CSV